The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
frontMIND: Phase 3 study of tafasitamab (Tafa) plus lenalidomide (Len) and R-CHOP for patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL).
 
Georg Lenz
Honoraria - Abbvie; ADC Therapeutics; AstraZeneca; BeiGene/BeOne; Bristol-Myers Squibb; Exscientia; Genmab; Gilead Sciences; GlaxoSmithKline; Hexal; Immagene/Flindr; Incyte; Lilly; Miltenyi Biotec; MSD; Novartis; Pentixapharm; Pierre Fabre; Roche/Genentech; Sobi
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; BeiGene/BeONE; Bristol-Myers Squibb; Exscientia; Genmab; Gilead Sciences; GlaxoSmithKline; Hexal; Immagene/Flindr; Incyte; Lilly; Miltenyi Biotec; MSD; Novartis; Pentixapharm; Pierre Fabre; Roche/Genentech; SOBI
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Gilead Sciences (Inst); Novartis (Inst); Roche/Genentech (Inst); SOBI (Inst)
Expert Testimony - Roche
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; BeiGene/BeONE; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Incyte; Novartis; Roche/Genentech; SOBI
 
Marek Trnený
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Janssen; MorphoSys; Novartis; Roche; SOBI; Swixx BioPharma; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Autolus; Bristol-Myers Squibb; Caribou Biosciences; Genmab; Gilead Sciences; Incyte; Janssen; MorphoSys; Novartis; Roche; SOBI; Takeda
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; janssen; Roche; SOBI; Takeda
 
John Burke
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol Myers Squibb; CRISPR Therapeutics; Genentech/Roche; Lilly
Travel, Accommodations, Expenses - Genentech/Roche
 
Grzegorz Nowakowski
Employment - Daiichi Sankyo, Inc
Consulting or Advisory Role - Abbvie; Bantam Pharmaceutical; Bristol-Myers Squibb/Celgene; Celgene (Inst); Debiopharm Group; Genentech (Inst); Genmab; Karyopharm Therapeutics; Kite/Gilead; kymera; MorphoSys (Inst); Roche Pharma AG (Inst); Ryvu Therapeutics; Selvita; TG Therapeutics
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)
 
Christopher Fox
Honoraria - Abbvie; Incyte; Roche; SERB Pharmaceuticals
Consulting or Advisory Role - Abbvie; Arvinas; AstraZeneca; Bristol-Myers Squibb; Genmab; Incyte; Kite/Gilead; MorphoSys; Ono Pharmaceutical; Roche; SERB Pharmaceuticals
Speakers' Bureau - Abbvie; Roche
Research Funding - Abbvie (Inst); BeOne Medicines (Inst); Genmab (Inst); Incyte (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Abbvie; Roche
 
Annalisa Chiappella
Consulting or Advisory Role - Abbvie; Gilead-Sciences/Kite Pharma Inc; Incyte; SOBI
Speakers' Bureau - Gilead-Sciences/Kite Pharma Inc.; Lilly
 
Johannes Dull
Consulting or Advisory Role - Abbvie; BeOne Medicines; Incyte
Research Funding - Incyte (Inst)
 
Youngwoo Jeon
No Relationships to Disclose
 
Chan Cheah
Consulting or Advisory Role - AstraZeneca (Inst); Gilead Sciences (Inst); Janssen-Cilag (Inst); Loxo/Lilly (Inst); Roche/Genentech (Inst)
Speakers' Bureau - Abbvie; AstraZeneca; BeOne Medicines; Genmab; Janssen; MSD; Roche
Research Funding - AbbVie (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - BeOne Medicines; Lilly
 
Jason Westin
Consulting or Advisory Role - Abbvie; Abbvie; ADC Therapeutics; Allogene Therapeutics; AstraZeneca; Bristol-Myers Squibb/Celgene/Juno; Chugai Pharma; Genentech/Roche; Genmab; Janssen Scientific Affairs; Kite/Gilead; Lyell Immunopharma; Merck; MorphoSys/Incyte; Novartis; Nurix; Regeneron; Seagen
Research Funding - ADC Therapeutics; Allogene Therapeutics; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Janssen; Kite/Gilead; MorphoSys/Incyte; Novartis; Nurix
 
Joseph Ye
No Relationships to Disclose
 
Priscilla Caguioa
No Relationships to Disclose
 
David Belada
Consulting or Advisory Role - AstraZeneca; BMS; Bristol Myers Squibb Foundation; Dr. Reddy's; Genmab; Gilead Sciences; Janssen-Cilag; MorphoSys; Roche; Takeda
Research Funding - AstraZeneca (Inst); Dr. Reddy's (Inst); Genmab (Inst); Gilead Sciences (Inst); Janssen-Cilag (Inst); MorphoSys (Inst); Pharmacyclics (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Roche; Takeda
 
Ho Jin Shin
No Relationships to Disclose
 
Sung Yong Oh
No Relationships to Disclose
 
Sandy Amorim
No Relationships to Disclose
 
Philomena Colucci
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Sonia Ioannidis
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Lulu Cheng
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Umberto Vitolo
Honoraria - Abbvie; AstraZeneca; Genmab; Gilead Sciences; Incyte; MSD; Roche; Sobi
Consulting or Advisory Role - Abbvie; Genmab; Gilead Sciences; Incyte; MSD; Regeneron; Sobi